SCHEMBL4835473

SCHEMBL4835473

COc1ccc2c(c1)/C(=C/C(=O)c1ccc(NC(=O)c3cccc([N+](=O)[O-])c3)cc1)NC(C)(C)C2

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
ALDH1A1 P00352 4/20 0.59
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
PLG P00747 1/20 0.51
PLAU P00749 1/20 0.51
PLAT P00750 1/20 0.51
MEN1 O00255 10/20 0.51
KMT2A Q03164 10/20 0.51
GPR17 Q13304 1/20 0.49
SETD7 Q8WTS6 1/20 0.48
LMNA P02545 4/20 0.47
ALOX5 P09917 1/20 0.47
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.46
THRA P10827 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4835479 1.00 MAPT (0.59) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4838226 0.94 MAPT (0.54) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4838218 0.94 MAPT (0.54) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4842456 0.92 ALOX5 (0.48) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4842463 0.92 ALOX5 (0.48) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4837792 0.91 KMT2A (0.51) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4837807 0.91 KMT2A (0.51) MAPTALDH1A1NPC1RAB9APLG
SCHEMBL4844456 0.90 KMT2A (0.58) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL4844461 0.90 KMT2A (0.58) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL4840829 0.89 KMT2A (0.46) MAPTALDH1A1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MAPT 646/4885ALDH1A1 2636/4885NPC1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.